Benjamin Lacas

Pooled Analysis of the Prognostic and Predictive Effects of <i>TP53</i> Comutation Status Combined With <i>KRAS</i> or <i>EGFR</i> Mutation in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Frances A. Shepherd, Benjamin Lacas, Gwénaël Le Teuff et al. · Journal of Clinical Oncology · 2017 · 133 citations · Full text

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier, Anne Floquet, Christine Chevreau et al. · The Lancet Oncology · 2015 · 112 citations

Gynecological Surgery, Medicine, Gynecology +6

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon et al. · The Lancet Oncology · 2021 · 100 citations · Full text

Adaptive Radiotherapy, Advanced Head, Neck Cancer +6

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis

Xiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas et al. · Journal of Thoracic Oncology · 2016 · 97 citations · Full text

Medicine, Clinical Trials, Pathology +12

Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

Claire Petit, Anne Lee, Jun Ma et al. · The Lancet Oncology · 2023 · 58 citations · Full text

Medicine, Cancer Management, Metronomic Therapy +8